ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2022

Individual Disease Burden in Children and Adolescents with Chronic Musculoskeletal Pain – Multilevel-Analysis of a Nationwide Prospective Longitudinal Observation Study

Kerstin Gerhold1, Rebecca Muckelbauer2, Jacqueline Müller-Nordhorn2, Angelika Thon3, Thomas Müller4, Gerd Ganser5, Martina Niewerth6 and Kirsten Minden7, 1Programme Area Epidemiology, German Rheumatism Research Center, a Leipniz Institute, Berlin, Germany, 2Berlin School of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany, 3Kinderklinik der Medizinischen Hochschule Hannover, Hannover, Germany, 4Universitätsklinikum Halle (Saale), Halle (Saale), Germany, 5Pediatric Rheumatology, Sankt Josef Stift, Sendenhorst, Germany, 6Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, 7Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Chronic pain, juvenile idiopathic arthritis (JIA) and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Chronic musculoskeletal pain was described to be a frequent complaint in children and adolescents with assumed relevant impairment of health-related quality of life (HRQoL) as crucial indicator of individual disease burden. Since only a few epidemiological data are available, we investigated the course of single dimensions of patient-assessed HRQoL in children and adolescents with either chronic idiopathic musculoskeletal pain (CIMP) or juvenile idiopathic arthritis (JIA) as two entities of chronic musculoskeletal pain.

Methods: The national pediatric database is an ongoing nationwide prospective observation study on health care of patients with rheumatic-inflammatory or other musculoskeletal diseases referring to pediatric rheumatology departments in Germany. Patients diagnosed with CIMP or JIA enrolled between 2000 and 2008 with a minimal observation period of two years were included in the present analyses. They evaluated annually single generic dimensions of HRQoL on numeric rating scales (NRS, 0-10, 0 best): pain severity, physical capability, limitation in daily life activities, and capability of disease coping. The method of linear multi-level analysis was used to predict two-year courses of these patient-reported outcome measures. Each statistical model was adjusted for sex, age at disease onset, disease duration, calendar year of documentation, and medical care level of recruiting departments (private practice, general children´s hospital, university children´s hospital).

Results: Data of 318 CIMP patients (70% females, age (mean ± sd) 12.0±3.8 years, disease duration 2.4±2.6 years) and 6,103 JIA patients (65% females, age 9.5±4.5 years, disease duration 2.7±3.1 years) were included. At baseline (t0), CIMP patients assessed all single generic dimensions of HRQoL with poorer scores than JIA patients: pain severity by plus 1.5 NSR points, limitation in daily life activities by plus 0.9, physical capability and disease coping by plus 0.5 NSR points each, and global health state by plus 0.7 NSR points. Compared to t0, values of single HRQoL dimensions decreased only in JIA up to one (t1) und two years (t2) of follow-up, but not in CIMP patients (t1 versus t0 p<0.001; t2 versus t0 p<0.001). CIMP patients evaluated single generic dimensions of HRQoL persistently worse than JIA patients; this group difference increased for all scales between t0 and t2(p<0.05).

Conclusion: Consistently poorer estimates of all investigated measures of HRQoL in children and adolescents with CIMP over the two-year observation period, compared to children with JIA, are first hints for a relevant and long-term burden of disease in these patients. These results may implicate the need for improving medical care conditions for these patients in Germany in order to avoid a possible long-lasting disease career beyond childhood and adolescence.

Support: The national pediatric database is financially supported by the Children´s Arthritis Foundation (Kinder-Rheumastiftung).


Disclosure:

K. Gerhold,
None;

R. Muckelbauer,
None;

J. Müller-Nordhorn,
None;

A. Thon,
None;

T. Müller,
None;

G. Ganser,
None;

M. Niewerth,
None;

K. Minden,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/individual-disease-burden-in-children-and-adolescents-with-chronic-musculoskeletal-pain-multilevel-analysis-of-a-nationwide-prospective-longitudinal-observation-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology